LC-MS/MS
Showing 26 - 50 of >10,000
COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
Completed
- Multiple Sclerosis
- Covid19
-
New York, New YorkNYU Langone Health
Nov 2, 2022
Advanced Solid Tumor Trial in Bengbu, Hefei, Changsha (TT-00973-MS tablets treatment)
Not yet recruiting
- Advanced Solid Tumor
- TT-00973-MS tablets treatment
-
Bengbu, Anhui, China
- +2 more
Jan 9, 2023
Multiple Sclerosis Trial (Cognitive training, Motor training)
Recruiting
- Multiple Sclerosis
- Cognitive training
- Motor training
-
Brussel, Belgium
- +1 more
Nov 4, 2022
Long-Term Safety of Vumerity and Tecfidera in Multiple Sclerosis
Not yet recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +2 more
- (no location specified)
Mar 2, 2023
COVID-19 Vaccine Response in Treated MS Patients
Recruiting
- Multiple Sclerosis
- Healthy
- Blood draw
-
Boston, MassachusettsBrigham MS Center
Jul 26, 2022
Multiple Sclerosis, Obesity Trial in Kansas City (behavioral telehealth, Treatment as Usual)
Active, not recruiting
- Multiple Sclerosis
- Obesity
- behavioral telehealth
- Treatment as Usual
-
Kansas City, MissouriUniversity of Missouri-Kansas City
Nov 1, 2022
Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal
Recruiting
- Multiple Sclerosis
- Voice analysis
-
Bern, SwitzerlandInselspital University Hospital Bern
Dec 5, 2022
Corrona Multiple Sclerosis (MS) Registry
Enrolling by invitation
- Multiple Sclerosis
-
Waltham, MassachusettsCorrona, LLC
Nov 9, 2022
Multiple Sclerosis Trial in San Francisco, Cleveland (Multiple Sclerosis Clinical Care Delivery via telehealth, Multiple
Not yet recruiting
- Multiple Sclerosis
- Multiple Sclerosis Clinical Care Delivery via telehealth
- Multiple Sclerosis Clinical Care Delivery via standard in clinic visits
-
San Francisco, California
- +1 more
Jan 3, 2023
Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Recruiting
- Prediabetes
- +3 more
- Oral Glucose Tolerance Test
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Oct 18, 2023
Ocrelizumab Effects on the Metabolome in MS
Active, not recruiting
- Multiple Sclerosis
-
Baltimore, MarylandJohns Hopkins University
Jan 30, 2023
MS Using a Mobile Application
Enrolling by invitation
- Multiple Sclerosis
- BeCare Mobile App
-
New York, New YorkWeill Cornell Medical College
Dec 22, 2022
Multiple Sclerosis (MS) Trial in Birmingham (Physical activity behavioral intervention in persons newly diagnosed with MS)
Recruiting
- Multiple Sclerosis (MS)
- Physical activity behavioral intervention in persons newly diagnosed with MS
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2023
MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study
Completed
- Multiple Sclerosis (MS)
-
Baltimore, Maryland
- +5 more
Sep 14, 2022
Difference in Regional Brain Activity Trial in Marseille (IRM multimodale a ultra-haute camp)
Recruiting
- Difference in Regional Brain Activity
- IRM multimodale a ultra-haute camp
-
Marseille, Bouches Du Rhône, FranceAssistance Publique Hopitaux Marseille
Oct 18, 2022
Turkish Version of F-2-MS
Not yet recruiting
- Cultural Adaptation
- +4 more
- Cultural adaptation, reliability and validity
- (no location specified)
Oct 19, 2022
Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)
Not yet recruiting
- Multiple Sclerosis
- MSCopilot® mobile application
-
Oklahoma City, Oklahoma
- +6 more
Apr 3, 2023
Determining Cognitive, Energetic, Behavioural and Affective
Recruiting
- Multiple Sclerosis
- There is no intervention.
-
Groningen, NetherlandsUniversity Medical Center Groningen (UMCG)
Aug 25, 2023
MS Patients Treated With Sphingosine-1-phosphate Receptor
Recruiting
- Multiple Sclerosis
- S1PR analysis on immune cells
-
Bern, SwitzerlandNeurology department
Apr 12, 2023
Multiple Sclerosis Trial (Seated Physical activity INtervention for persons with MS, "SPIN" program- Intervention Condition,
Not yet recruiting
- Multiple Sclerosis
- Seated Physical activity INtervention for persons with MS, "SPIN" program- Intervention Condition
- Wellness for MS (WellMS)- Control Condition
- (no location specified)
May 24, 2023
Multiple Sclerosis Trial (Ocrelizumab Injection [Ocrevus])
Not yet recruiting
- Multiple Sclerosis
- Ocrelizumab Injection [Ocrevus]
- (no location specified)
Aug 22, 2023
Spondyloarthropathy, Tendinopathy Trial in Bordeaux (MRI ZTE2 sequence)
Recruiting
- Spondyloarthropathy
- Tendinopathy
- MRI ZTE2 sequence
-
Bordeaux, FranceCHU de Bordeaux
Dec 26, 2022
PTSD Trial (CPT, MS)
Not yet recruiting
- PTSD
- CPT
- MS
- (no location specified)
Jul 27, 2022